ResMed Inc.
corporate_fare Company Profile
ResMed Inc. (NYSE:RMD) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 18 items for RMD at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-29, rated 7/10. Across its 18 most recent items scored 7 or higher, the top rating is 8/10, with 6 rated 8 or above. Recent SEC coverage for RMD spans 10-Q, 8-K, 10-K.
Recent high-impact activity:
- ResMed Q1 EPS $2.92 as MatrixCare Sale Adds $62M Gain
- ResMed Posts 1Q EPS of $2.92
- ResMed Launches $450M Accelerated Buyback Funded by MatrixCare Sale
- ResMed Launches $450M Accelerated Share Repurchase with Citibank
- ResMed Swaps Auditors from KPMG to PwC and Names Carol Burt Lead Director
Financial Snapshot
Short Interest & Short Volume
7.05 days to coverFINRA reported short interest of 10,471,435 shares in RMD as of the October 30, 2026 settlement, a 12.1% decrease from the prior period — about 7.0 days to cover at its recent average daily volume. On November 20, 2026, 89.2% of RMD volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.